InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: zoriden post# 9370

Monday, 03/03/2014 6:39:12 PM

Monday, March 03, 2014 6:39:12 PM

Post# of 48316
Phase2B following Phase2A would most likely retain IL-12 and add anti-PD-1. Safety is now proven with IL-12 so not very likely they would change IL-12 for an unknown IL-XX. Anti-PD-1 safety is already proven with Merck Clinical Trials led by Dr. Pierce.